Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of scoping reviews (the extension is also intended to apply to evidence maps). PRISMA-ScR Checklist (Word) PRISMA-ScR Checklist (PDF) |
| Full bibliographic reference | Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018. |
| Language | English |
| PubMed ID | 30178033 |
| Relevant URLs (full-text if available) |
The full-text of PRISMA-ScR is freely available from: http://annals.org/aim/fullarticle/2700389/prisma-extension-scoping-reviews-prisma-scr-checklist-explanation |
| Relevant more generic / specialised reporting guidelines (i.e. main generic guideline or extension to a generic guideline) |
Generic PRISMA Statement: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009; 6(7): e1000097. PMID: 19621072 BMJ. 2009; 339:b2535. PMID: 19622551 Ann Intern Med. 2009; 151(4):264-9, W64. PMID: 19622511 J Clin Epidemiol. 2009; 62(10):1006-12. PMID: 19631508 Open Med. 2009; 3(3);123-130. PMID: 21603045 Int J Surg. 2010;8(5):336-341. PMID: 20171303 Specialised PRISMA-Equity: Welch V, Petticrew M, Tugwell P, Moher D, O'Neill J, Waters E, White H; PRISMA-Equity Bellagio group. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity. PLoS Med. 2012;9(10):e1001333. PMID: 23222917 Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P; PRISMA-Equity Bellagio group. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. Int J Equity Health. 2015;14(1):92. PMID: 26450828 J Clin Epidemiol. 2015. PMID: 26348799 PRISMA-Abstracts: Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D; PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med. 2013;10(4):e1001419. PMID: 23585737 PRISMA-P: Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. PMID: 25554246 PRISMA-IPD: Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF; PRISMA-IPD Development Group. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313(16):1657-1665. PMID: 25919529 PRISMA extension for network meta-analyses: Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. Ann Intern Med. 2015;162(11):777-784. PMID: 26030634 PRISMA-harms: Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher D, Vohra S; PRISMA harms group. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ. 2016;352:i157. PMID: 26830668 PRISMA-CI: Guise JM, Butler ME, Chang C, Viswanathan M, Pigott T, Tugwell P; Complex Interventions Workgroup. AHRQ Series on Complex Intervention Systematic Reviews - Paper 6: PRISMA-CI Extension Statement & Checklist. J Clin Epidemiol. 2017. PMID: 28720516 PRISMA-DTA: McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; and the PRISMA-DTA Group. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388-396. PMID: 29362800 |
| Reporting guideline acronym | PRISMA-ScR |
| Study design | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews |
| Applies to the whole report or to individual sections of the report? | Whole report |
| Additional information | An introductory video and a series of tip sheets for reporting each PRISMA-ScR item are available at: https://knowledgetranslation.net/portfolios/the-prisma-scr-prisma-extension-for-scoping-reviews/ Read the executive summary for the development of PRISMA-ScR. |
| Record last updated on | September 26, 2019 |